Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04828278 · ClinicalTrials.gov registry record · NA
Nutrition21 Study 1
A NA study, sponsored by Texas A&M University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT04828278 is a NA study that has completed, run by Texas A&M University. The registered enrollment target is 24 participants.
The verdict
NCT04828278, a NA study, has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of nooLVL containing arginine and inositol supplementation on executive function and memory prior to and following playing video games.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Arginine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2020-04-06 |
| Est. Completion | 2021-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04828278
The ClinicalTrials.gov registry entry for NCT04828278 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04828278 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04828278 about?
NCT04828278 is a clinical study titled "Nutrition21 Study 1". The purpose of this study is to determine the effects of nooLVL containing arginine and inositol supplementation on executive function and memory prior to and following playing video games.
What is the current status of trial NCT04828278?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2020-04-06. Estimated completion is 2021-03-01.
What interventions are being tested in trial NCT04828278?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Arginine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04828278?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.